Miller Investment Management LP Sells 28,982 Shares of VanEck Pharmaceutical ETF $PPH

Miller Investment Management LP trimmed its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 15.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 152,936 shares of the company’s stock after selling 28,982 shares during the period. VanEck Pharmaceutical ETF comprises 1.5% of Miller Investment Management LP’s investment portfolio, making the stock its 16th biggest position. Miller Investment Management LP owned approximately 1.39% of VanEck Pharmaceutical ETF worth $15,778,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. AlphaCore Capital LLC bought a new stake in VanEck Pharmaceutical ETF in the 4th quarter worth about $31,000. IFP Advisors Inc grew its position in VanEck Pharmaceutical ETF by 53.7% in the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after purchasing an additional 153 shares in the last quarter. Advisory Services Network LLC purchased a new position in VanEck Pharmaceutical ETF in the third quarter valued at about $41,000. REAP Financial Group LLC purchased a new position in VanEck Pharmaceutical ETF in the fourth quarter valued at about $52,000. Finally, CWM LLC boosted its stake in VanEck Pharmaceutical ETF by 36.3% in the fourth quarter. CWM LLC now owns 511 shares of the company’s stock valued at $53,000 after acquiring an additional 136 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Down 0.6%

PPH opened at $105.29 on Thursday. The stock has a market cap of $999.20 million, a price-to-earnings ratio of 20.21 and a beta of 0.47. VanEck Pharmaceutical ETF has a twelve month low of $81.74 and a twelve month high of $112.58. The company’s 50-day moving average price is $102.91 and its two-hundred day moving average price is $104.29.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Wednesday, April 1st were paid a $0.8441 dividend. The ex-dividend date was Wednesday, April 1st. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $3.38 dividend on an annualized basis and a yield of 3.2%.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.